LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Momelotinib | 1.11 | uM | LJP5 | 2 | P09 | 72 | hr | 1657 | 4339 | 5505 | 0.7881 | 0.6968 |
| BT-20 | Momelotinib | 1.11 | uM | LJP5 | 3 | P09 | 72 | hr | 1657 | 4207 | 5505 | 0.7641 | 0.6625 |
| BT-20 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1657 | 1528 | 5505 | 0.2775 | -0.0337 |
| BT-20 | Dasatinib | 1.11 | uM | LJP5 | 2 | D03 | 72 | hr | 1657 | 1687 | 5505 | 0.3064 | 0.0076 |
| BT-20 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 1657 | 1527 | 5505 | 0.2774 | -0.0340 |
| BT-20 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1657 | 1570 | 5505 | 0.2852 | -0.0228 |
| BT-20 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1657 | 1541 | 5505 | 0.2799 | -0.0303 |
| BT-20 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1657 | 1248 | 5505 | 0.2267 | -0.1065 |
| BT-20 | Dovitinib | 1.11 | uM | LJP5 | 1 | E21 | 72 | hr | 1657 | 3293 | 5505 | 0.5981 | 0.4250 |
| BT-20 | Dovitinib | 1.11 | uM | LJP5 | 2 | E21 | 72 | hr | 1657 | 2639 | 5505 | 0.4793 | 0.2550 |
| BT-20 | Dovitinib | 1.11 | uM | LJP5 | 3 | E21 | 72 | hr | 1657 | 2618 | 5505 | 0.4755 | 0.2496 |
| BT-20 | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 1657 | 6335 | 5505 | 1.1506 | 1.2155 |
| BT-20 | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 1657 | 6299 | 5505 | 1.1441 | 1.2062 |
| BT-20 | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 1657 | 6543 | 5505 | 1.1884 | 1.2696 |
| BT-20 | Erlotinib | 1.11 | uM | LJP5 | 1 | M21 | 72 | hr | 1657 | 4881 | 5505 | 0.8865 | 0.8377 |
| BT-20 | Erlotinib | 1.11 | uM | LJP5 | 2 | M21 | 72 | hr | 1657 | 5051 | 5505 | 0.9174 | 0.8818 |
| BT-20 | Erlotinib | 1.11 | uM | LJP5 | 3 | M21 | 72 | hr | 1657 | 4773 | 5505 | 0.8669 | 0.8096 |
| BT-20 | Foretinib | 1.11 | uM | LJP5 | 1 | H09 | 72 | hr | 1657 | 1783 | 5505 | 0.3239 | 0.0326 |
| BT-20 | Foretinib | 1.11 | uM | LJP5 | 2 | H09 | 72 | hr | 1657 | 1754 | 5505 | 0.3186 | 0.0250 |
| BT-20 | Foretinib | 1.11 | uM | LJP5 | 3 | H09 | 72 | hr | 1657 | 1757 | 5505 | 0.3191 | 0.0258 |
| BT-20 | R406 | 1.11 | uM | LJP6 | 1 | C15 | 72 | hr | 1657 | 5455 | 5505 | 0.9908 | 0.9868 |
| BT-20 | R406 | 1.11 | uM | LJP6 | 2 | C15 | 72 | hr | 1657 | 5261 | 5505 | 0.9556 | 0.9364 |
| BT-20 | R406 | 1.11 | uM | LJP6 | 3 | C15 | 72 | hr | 1657 | 5655 | 5505 | 1.0271 | 1.0388 |
| BT-20 | Pictilisib | 1.11 | uM | LJP6 | 1 | D21 | 72 | hr | 1657 | 2269 | 5505 | 0.4121 | 0.1589 |
| BT-20 | Pictilisib | 1.11 | uM | LJP6 | 2 | D21 | 72 | hr | 1657 | 2155 | 5505 | 0.3914 | 0.1292 |